Reduce Soreness and Recover Post-Workout* When youre sore, the following days you dont perform as well in the gym
In patients with clinical ASCVD and possible SASEs who have failed at least 2 (and preferably 3) statins, including a trial of 1 attempt at the lowest approved dose or using alternative statin dosing, or who still have not achieved adequate reduction in LDL-C or nonHDL-C on maximally tolerated statin therapy, a trial of ezetimibe or a PCSK9 mAb may be considered as first-line nonstatin therapy (see Figure 7), depending on the patients clinical scenario
Brain Res 709, 122301 (1996)
It has shown promise in healing injuries, reducing inflammation, and promoting gut health
Chronic kidney disease after acute kidney injury: A systematic review and meta-analysis
Lumjuan N, MaCarroll L, Prapanthadara LA, Hemingway J, Ranson H